Spain· ES:88034
IMIKERADERM 50 MG/G CREMA
A medicinal product containing imiquimod, registered in Spain by Mibe Pharma España S.L.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- imiquimod
- Manufacturer
- Mibe Pharma España S.L.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cima_codigo75815312EUR 37.78
- cima_codigo75815424EUR 75.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imiquimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesImiquimodPadagis Israel Pharmaceuticals Ltd
- FranceBASCELLEX 50 mg/g, crèmeSUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- NetherlandsBascellex 50 mg/g crèmeSun Pharmaceutical Industries Europe B.V.
- PolandImikeradermSun-Farm Sp. z o.o.
- SwedenBascellex 50 mg/g KrämSun Pharmaceutical Industries Europe B.V.
- United KingdomAldara 5% cream 250mg sachetsViatris UK Healthcare Ltd
- FinlandAldaraOrifarm Oy
- CzechiaALDARAVIATRIS HEALTHCARE LIMITED, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Imikeraderm
- Cyprus · Modiwart
- Germany · Aksunim, Imikeraderm
- United Kingdom (Northern Ireland) · Bascellex
- Greece · Modiwart, Quimodia
- Iceland · Aldara, Zyclara
- Italy · Imunocare
- Liechtenstein · Aldara, Zyclara
- Netherlands · Bascellex
- Norway · Aldara, Bascellex
- Poland · Imikeraderm
- Portugal · Imicare
- Sweden · Bascellex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7618a203-bd45-492f-955b-98cd5b776d18 GET /v1/drugs/7618a203-bd45-492f-955b-98cd5b776d18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1660205327000}",
"nregistro": "88034",
"substance": "imiquimod"
}See everything about imiquimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.